Table 2.
Endogenous DNA lesions | Notes | Refs. [182] |
---|---|---|
Abasic sites | Apurinic and apyrimidinic sites; BER* | [183–186] |
Processed abasic sites | BER intermediates | [187] |
8-oxoguanine/8-oxoadenine | Free radicals; weak topoisomerase II poison | [185] |
O6-methylguanine | Free radicals; weak topoisomerase II poison | [185] |
Deoxyuracil | Cytosine deamination | [188] |
Base mismatches | DNA replication | [188,189] |
Ribonucleotides | DNA replication | [190,191] |
1,N6-ethenodeoxyadenine | Lipid peroxidation; industrial chemicals | [185,186] |
1,N2-ethenodeoxyguanosine | Lipid peroxidation; industrial chemicals | [186] |
3,N4-ethenodeoxycytidine | Lipid peroxidation; industrial chemicals | [186] |
3,N4-ethenodeoxycytidine | Lipid peroxidation; industrial chemicals | [186] |
M1dG | Lipid peroxidation; industrial chemicals | [186] |
Single-stranded DNA breaks | Free radicals; cellular processes | [192,193] |
Exogenous DNA lesions
| ||
UV lesions | Cyclobutane dimers | [194] |
Cytosine arabinoside | Cytarabine-induced DNA lesions | [195] |
Ethenobase adducts | Chloracetaldehyde treatment of cells | [186] |
benzo[a]pyrene 7,8-diol 9,10-epoxide deoxyadenosine | Intercalated carcinogenic adducts | [196] |
BER: base excision repair.